home / stock / fold / fold articles

FOLD Articles, Amicus Therapeutics Inc.

Stock Information
Company Name: Amicus Therapeutics Inc.
Stock Symbol: FOLD
Market: NASDAQ
Website: amicusrx.com
Menu
FOLD FOLD Quote FOLD Short FOLD News FOLD Articles FOLD Message Board
Get FOLD Alerts

News, Short Squeeze, Breakout and More Instantly...
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga

PRINCETON, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced that management will participate in a fires...
This Boston Beer Analyst Turns Bullish; Here Are Top 5 Upgrades For Today. | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference | Benzinga

PRINCETON, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced that management will participate in a firesi...

Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024 | Benzinga

PRINCETON, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced that management will participate in upcomi...
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook | Benzinga

2023 Total Revenue of ~$399.4M, a 21% Increase Year-Over-Year >2,400 People Living with Fabry Disease on Galafold® Following a Year of Inc...

Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO | Benzinga

Crowley to Step Down from Amicus Board of Directors in March 2024 and Become Amicus Chairman Emeritus Michael Raab, Current Lead Independent Dire...

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023 | Benzinga

PRINCETON, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced that management will participate in upcomin...
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023 | Benzinga

PRINCETON, N.J., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced that the Company will host a conference cal...

Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration | Benzinga

Refinancing of Current $400M Debt at Lower Cost and Improved Amortization Schedule Blackstone to also Purchase $30M of Amicus Common Stock PRINCET...

Nike, OPKO Health And Other Big Stocks Moving Higher In Friday's Pre-Market Session | Benzinga

U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording gains in today’s pre-market trading session. Bro...
Next 10